Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase capacity in phlebotomy services.

Blood tests are among the most commonly requested diagnostic investigations across primary and secondary care, and they are readily available across all 27 National Health Service pathology networks. Phlebotomy – the procedure to collect blood samples – is widely available across general practice, community health services, and secondary care phlebotomy clinics, supporting equitable access to blood testing.

Where phlebotomy services are provided by general practice, they are commissioned locally by integrated care boards (ICBs). ICBs are responsible for commissioning phlebotomy services based on local population need and are funded for these services as part of their annual funding allocations.

In January 2025, we published the Elective Reform Plan, which sets out the productivity and reform efforts needed to return to the 18-week constitutional standard by the end of this parliament. The Plan commits to transform and expand diagnostic services and speed up waiting times for tests, a crucial part of reducing overall waiting times.

Community Diagnostic Centres (CDCs), including those in Gloucestershire and Herefordshire, are supporting one of the governments key strategic shifts – moving care from the hospital to the community. CDCs offer local populations a wide range of diagnostic tests, including phlebotomy, closer to home and greater choice on where and how they are undertaken.

We are continuing to invest in expanding diagnostic capacity in the NHS. As set out in the Elective Reform Plan, we plan to build up to five more CDCs in 2025/26, alongside increasing the operating hours of existing sites so that more offer services 12 hours a day, seven days a week. This is backed by part of the £600 million of capital investment for diagnostic services announced at the October 2024 Spending Review.